JCG
AERI

JHL Capital Group’s Aerie Pharmaceuticals AERI Stock Holding History

JHL Capital Group’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-195,000
Closed -$4.04M – 29
2014
Q3 		$4.04M Buy
+195,000
New +$3.84M 0.22% 23

Other funds holding AERI

CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

JHL Capital Group's AERI Position: Q4 2014 in Review

JHL Capital Group sold out of Aerie Pharmaceuticals (AERI) in Q4 2014, closing a stake of 195,000 shares — an estimated $4.04M sold.

JHL Capital Group first reported a position in AERI in Q3 2014 and held it in 1 quarter. The position peaked at $4.04M in Q3 2014. 98 funds tracked by Wall St. Rank hold AERI as of Q4 2014.

  • JHL Capital Group reported no remaining Aerie Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • JHL Capital Group sold 195,000 Aerie Pharmaceuticals shares in Q4 2014, an estimated $4.04M.
  • JHL Capital Group first reported a position in Aerie Pharmaceuticals in Q3 2014 and held it in 1 quarter.
  • JHL Capital Group's Aerie Pharmaceuticals position peaked at $4.04M in Q3 2014.
  • 98 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2014.

Based on JHL Capital Group's 13F filing for Q4 2014, filed 17 Feb 2015.